The US Food and Drug Administration has issued an import alert for drugs manufactured at Dabur India's factory in India's western region of Dadra and Nagar Haveli following an inspection, the consumer goods company said on Thursday.
The action was taken after the FDA inspected the factory and flagged data integrity and maintenance lapses.